[go: up one dir, main page]

NO20065748L - Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie - Google Patents

Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie

Info

Publication number
NO20065748L
NO20065748L NO20065748A NO20065748A NO20065748L NO 20065748 L NO20065748 L NO 20065748L NO 20065748 A NO20065748 A NO 20065748A NO 20065748 A NO20065748 A NO 20065748A NO 20065748 L NO20065748 L NO 20065748L
Authority
NO
Norway
Prior art keywords
related diseases
foods
lifestyle
turmerone
preventing
Prior art date
Application number
NO20065748A
Other languages
English (en)
Norwegian (no)
Inventor
Tatsumasa Mae
Hideyuki Kishida
Tozo Nishiyama
Ryoji Takagaki
Masaji Yamamoto
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of NO20065748L publication Critical patent/NO20065748L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20065748A 2004-05-31 2006-12-13 Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie NO20065748L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004161590 2004-05-31
PCT/JP2005/009903 WO2005115366A1 (ja) 2004-05-31 2005-05-30 ウコン精油成分を含有する生活習慣病予防・改善剤

Publications (1)

Publication Number Publication Date
NO20065748L true NO20065748L (no) 2007-02-28

Family

ID=35450639

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065748A NO20065748L (no) 2004-05-31 2006-12-13 Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie

Country Status (10)

Country Link
US (1) US20080312333A1 (ja)
EP (1) EP1752144A4 (ja)
JP (1) JPWO2005115366A1 (ja)
CN (1) CN1956713A (ja)
AU (1) AU2005247251A1 (ja)
CA (1) CA2566202A1 (ja)
NO (1) NO20065748L (ja)
RU (1) RU2006147249A (ja)
TW (1) TW200538052A (ja)
WO (1) WO2005115366A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007131603A (ja) * 2005-11-14 2007-05-31 Kaneka Corp L−カルニチン合成系酵素遺伝子の転写促進用組成物
JPWO2008038712A1 (ja) * 2006-09-27 2010-01-28 国立大学法人 熊本大学 メタボリックシンドロームの治療・予防剤
EP2223616A1 (de) * 2009-02-13 2010-09-01 PM-International AG Nahrungsergänzungsmittelpräparat mit einer Wirksubstanzmischung
SG178191A1 (en) 2009-07-31 2012-03-29 Cognition Therapeutics Inc Inhibitors of cognitive decline
JP5578822B2 (ja) * 2009-09-25 2014-08-27 株式会社ピカソ美化学研究所 アセチルコリンエステラーゼ阻害剤
CN103458885B (zh) 2011-02-02 2016-02-10 考格尼申治疗股份有限公司 由姜黄油分离的化合物及使用方法
CN102488773A (zh) * 2011-12-30 2012-06-13 苏州爱斯欧蒂生物科技有限公司 一种多功能保健品
JP6517827B2 (ja) 2014-01-31 2019-05-22 コグニション セラピューティクス,インコーポレイテッド イソインドリン組成物および神経変性疾患の治療方法
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
CN107089992B (zh) * 2017-06-07 2019-11-22 浙江大学 一种姜黄属植物总倍半萜及三种倍半萜单体及制备方法和用途
CN111278301A (zh) * 2017-10-31 2020-06-12 好侍食品集团本社株式会社 甜没药姜黄醇提取方法
JP6709001B1 (ja) 2019-07-01 2020-06-10 ハウスウェルネスフーズ株式会社 TNF−α又はIL−6産生抑制用組成物
JP7637357B2 (ja) * 2020-09-29 2025-02-28 学校法人近畿大学 血管保護のためのターメリックオイルを含有する組成物、ならびにこのような組成物を含む飲食品および香料
CN113087690B (zh) * 2021-03-31 2024-02-13 黄山学院 一种中压制备色谱快速提取莪术有效成分的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07149628A (ja) * 1993-11-30 1995-06-13 Suntory Ltd 脂質代謝改善剤
JPH08187066A (ja) * 1995-01-09 1996-07-23 Yamada Houseki:Goushi 粒状ウコン茶およびこれの製造方法
JP3327757B2 (ja) * 1995-10-17 2002-09-24 丸善製薬株式会社 ビサボラン型セスキテルペン組成物およびその製造法
JP2873678B2 (ja) * 1996-09-18 1999-03-24 利夫 高梨 ウコンの苦味除去抑制方法
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
JP4179494B2 (ja) * 2001-10-23 2008-11-12 株式会社カネカ ペルオキシソーム増殖剤応答性受容体リガンド剤
US6991814B2 (en) * 2001-12-13 2006-01-31 Council Of Scientific And Industrial Research Herbal medicaments for the treatment of neurocerebrovascular disorders
CA2473874C (en) * 2001-12-14 2011-11-22 Council Of Scientific And Industrial Research A composition for treating neurocerebrovascular disorders
JP2004331539A (ja) * 2003-05-06 2004-11-25 Maruzen Pharmaceut Co Ltd 肝臓疾患予防治療剤及び肝臓疾患予防治療用飲食物
JP2005008572A (ja) * 2003-06-19 2005-01-13 Yakult Honsha Co Ltd リパーゼ阻害剤

Also Published As

Publication number Publication date
CA2566202A1 (en) 2005-12-08
EP1752144A4 (en) 2007-07-11
EP1752144A1 (en) 2007-02-14
WO2005115366A1 (ja) 2005-12-08
CN1956713A (zh) 2007-05-02
TW200538052A (en) 2005-12-01
AU2005247251A1 (en) 2005-12-08
US20080312333A1 (en) 2008-12-18
JPWO2005115366A1 (ja) 2008-03-27
RU2006147249A (ru) 2008-07-20

Similar Documents

Publication Publication Date Title
NO20065748L (no) Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie
El‐Hadary et al. Phenolic profiles, antihyperglycemic, antihyperlipidemic, and antioxidant properties of pomegranate (Punica granatum) peel extract
Grant et al. Diet’s role in modifying risk of Alzheimer’s disease: history and present understanding
Yin et al. Effects of lycopene on metabolism of glycolipid in type 2 diabetic rats
Debreceni et al. The role of homocysteine‐lowering B‐vitamins in the primary prevention of cardiovascular disease
Tremblay et al. Capsaicinoids: a spicy solution to the management of obesity?
Lampe Spicing up a vegetarian diet: chemopreventive effects of phytochemicals
CL2007002972A1 (es) Compuestos derivados de imidazolona e imidazolidinona, inhibidores de la 11b-hsd1; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para el tratamiento y prevencion de diabetes, obesidad, trastornos alimentarios, disl
Raju et al. Management of statin intolerance
Milaneschi et al. Nutritional determinants of mobility
CL2007001945A1 (es) Compuestos derivados de alquilpiridazina, inhibidores de 11 beta-hsd1; proceso de obtencion de los compuestos; composicion farmaceutica que los comprenden; y usos en el tratamiento de la diabetes, obesidad, trastorno de ingestion de comida, dislipide
Ponzo et al. Resveratrol: a supplementation for men or for mice?
Ibrahim et al. Metabolic impacts of high dietary exposure to persistent organic pollutants in mice
Berger Nutrition and micronutrient therapy in critical illness should be individualized
Przygodzka et al. Effect of selected spices on chemical and sensory markers in fortified rye‐buckwheat cakes
NO20054798L (no) Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer
JP2017515499A5 (ja)
MX369540B (es) Composicion de sustancias oleosas, picantes y odoriferas y un proceso para la preparacion de las mismas.
Mudumbi et al. The role of pollutants in type 2 diabetes mellitus (T2DM) and their prospective impact on phytomedicinal treatment strategies
Gupta et al. Resveratrol: A chemo-preventative agent with diverse applications
Dharmarajan Is vitamin supplementation appropriate in the healthy old?
Al-Malki Inhibition of α‐Glucosidase by Thiosulfinate as a Target for Glucose Modulation in Diabetic Rats
BR0317474A (pt) Antioxidante para gorduras, óleos e alimentos
Siddiqui et al. Role of herbal formulation of garlic on lipid profile in patients with type 2 diabetes related dyslipidemia
Otero-Losada et al. Antioxidants supplementation in elderly cardiovascular patients